ICU Medical, Inc. (NASDAQ:ICUI) Shares Purchased by KBC Group NV

KBC Group NV grew its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 2,498.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,303 shares of the medical instruments supplier’s stock after purchasing an additional 16,637 shares during the period. KBC Group NV owned approximately 0.07% of ICU Medical worth $2,685,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the company. Millennium Management LLC raised its holdings in shares of ICU Medical by 327.8% in the 2nd quarter. Millennium Management LLC now owns 136,070 shares of the medical instruments supplier’s stock valued at $16,158,000 after buying an additional 104,264 shares during the period. FMR LLC grew its position in ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock valued at $18,968,000 after acquiring an additional 100,345 shares in the last quarter. State Street Corp increased its stake in ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock worth $165,384,000 after purchasing an additional 77,506 shares during the period. Geode Capital Management LLC lifted its position in shares of ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock worth $99,687,000 after purchasing an additional 48,106 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of ICU Medical by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock valued at $54,868,000 after purchasing an additional 27,927 shares during the period. 96.10% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Christian B. Voigtlander sold 1,962 shares of the company’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96. The disclosure for this sale can be found here. Insiders have sold 17,737 shares of company stock valued at $2,879,752 over the last quarter. 6.70% of the stock is owned by insiders.

Analyst Ratings Changes

Several brokerages recently weighed in on ICUI. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective on the stock in a research report on Wednesday, December 11th. KeyCorp increased their price objective on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Finally, StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, ICU Medical has an average rating of “Moderate Buy” and a consensus price target of $199.67.

ICU Medical Trading Down 0.9 %

Shares of NASDAQ:ICUI opened at $164.36 on Friday. The company has a market cap of $4.02 billion, a PE ratio of -35.96 and a beta of 0.63. The company’s 50 day moving average is $160.98 and its two-hundred day moving average is $162.07. ICU Medical, Inc. has a 52 week low of $86.80 and a 52 week high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.